Circle Pharma
280 Utah Avenue
Suite 100
South San Francisco
California
94080-6883
United States
Tel: 650-392-0363
Website: http://circlepharma.com/
Email: info@circlepharma.com
About Circle Pharma
Founded by computational chemist Prof. Matthew Jacobson (UC San Francisco) and peptide chemist Prof. Scott Lokey (UC Santa Cruz), Circle Pharma is developing a new paradigm for macrocycle drug discovery. Circle’s technology facilitates the design and synthesis of intrinsically cell-permeable macrocycles that can address both intra- and extra-cellular therapeutic targets, and can be delivered by oral administration. Circle’s macrocycle development platform is applicable across a wide range of serious diseases; the company is initially focusing its internal development efforts on intracellular protein-protein interactions that are key drivers in cancer.YEAR FOUNDED:
2012
LEADERSHIP:
Founders: Mattew P. Jacobson and R. Scott Lokey
CEO: David J. Earp, JD, PhD
JOBS:
Please click here for Circle Pharma job opportunities.
CLINICAL TRIAL:
Please click here for clinical trial information.
7 articles about Circle Pharma
-
BioSpace Movers & Shakers, May 29
5/29/2020
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers. -
"We are delighted to have these premier life science investors supporting our Series B financing," said David J. Earp, Circle’s President and CEO.
-
Circle Pharma Announces Publication in Journal of Medicinal Chemistry of Results from Collaboration with Pfizer Inc.
1/17/2018
The goal of the collaboration was to deploy Circle’s rational design platform for macrocycle therapeutics in order to improve the drug-like characteristics of an existing macrocycle compound, and in particular to develop a cell permeable, orally bioavailable compound with enhanced target affinity.
-
Circle Pharma Announces Appointment of David Spellmeyer, PhD, as Chief Scientific Officer
11/20/2017
Dr. Spellmeyer brings over 25 years of broad industrial experience to Circle. He previously served as CTO & CIO at Nodality,
-
Circle Pharma Announces Expansion Of Series A Financing And Appointment Of James C. Lu To Its Board
4/25/2017
-
Circle Pharma, Developer Of Macrocyclic Peptide Therapeutics, Announces Series A Financing And Appoints Walter H. Moos, Ph.D., To Its Board
12/21/2016
-
Circle Pharma Enters Into An Agreement With Pfizer To Build Screening Library Of Macrocyclic Peptides
9/12/2016